AIM:TLY

Stock Analysis Report

Executive Summary

Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom.

Snowflake

Fundamentals

High growth potential with adequate balance sheet.

Risks

  • Totally is covered by less than 3 analysts.

Share Price & News

How has Totally's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.6%

TLY

1.1%

GB Healthcare

0.4%

GB Market


1 Year Return

-54.4%

TLY

-10.8%

GB Healthcare

-0.9%

GB Market

TLY underperformed the Healthcare industry which returned -10.5% over the past year.

TLY underperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -0.7% over the past year.


Share holder returns

TLYIndustryMarket
7 Day-1.6%1.1%0.4%
30 Day-2.1%22.0%4.4%
90 Day-6.1%11.6%0.5%
1 Year-54.4%-54.4%-9.3%-10.8%3.9%-0.9%
3 Year-86.2%-86.2%-10.2%-14.3%20.5%6.1%
5 Year-76.8%-76.8%110.2%99.2%33.2%5.1%

Price Volatility Vs. Market

How volatile is Totally's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Totally undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Totally's share price is below the future cash flow value, and at a moderate discount (> 20%).

Totally's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Totally is loss making, we can't compare its value to the GB Healthcare industry average.

Totally is loss making, we can't compare the value of its earnings to the United Kingdom of Great Britain and Northern Ireland market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Totally, we can't assess if its growth is good value.


Price Based on Value of Assets

Totally is good value based on assets compared to the GB Healthcare industry average.


Next Steps

Future Growth

How is Totally expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

54.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Totally's revenue is expected to grow significantly at over 20% yearly.

Totally's earnings are expected to grow significantly at over 20% yearly.

Totally's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.

Totally's earnings growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.

Totally's earnings growth is expected to exceed the low risk savings rate of 1.2%.


Earnings per Share Growth Estimates


Future Return on Equity

Totally is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Totally performed over the past 5 years?

9.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Totally does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Totally's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Totally's 1-year growth to the GB Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Totally has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Totally has efficiently used its assets last year compared to the GB Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Totally improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Totally's financial position?


Financial Position Analysis

Totally's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Totally's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Totally has no debt.

Totally currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet

Low level of unsold assets.

Totally has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Totally has sufficient cash runway for 2.9 years based on current free cash flow.

Unable to confirm if Totally has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is Totally's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Totally's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Totally's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Totally has not reported any payouts.

Unable to verify if Totally's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Totally has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Totally's salary, the management and board of directors tenure and is there insider trading?

1.9yrs

Average management tenure


CEO

Wendy Lawrence (57yo)

6.3yrs

Tenure

UK£163,000

Compensation

Mrs. Wendy Jayne Lawrence serves as Chief Executive and Managing Director at Totally Health Limited. Mrs. Lawrence has been the Chief Executive Officer of Totally plc since May 2013 and served as its Actin ...


CEO Compensation Analysis

Wendy's remuneration is lower than average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.

Wendy's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

1.9yrs

Average Tenure

53.5yo

Average Age

The average tenure for the Totally management team is less than 2 years, this suggests a new team.


Board Age and Tenure

3.8yrs

Average Tenure

64yo

Average Age

The tenure for the Totally board of directors is about average.


Insider Trading

More shares have been bought than sold by Totally individual insiders in the past 3 months, but not in substantial volumes.


Recent Insider Transactions

BuyUK£8,05110 Sep 19
Michael Rogers
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares84,000
Max PriceUK£0.096
BuyUK£1,89310 Sep 19
Wendy Lawrence
EntityIndividual
Role
Chief Executive Officer
CEO & Executive Director
Shares20,000
Max PriceUK£0.095
BuyUK£10,93324 Jun 19
Robert Holt
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares111,000
Max PriceUK£0.099
BuyUK£4,96921 Jun 19
Gloria Cooke
EntityIndividual
Role
Member of the Board of Directors
Clinical Quality Director & Director
Shares50,500
Max PriceUK£0.098
SellUK£358,62118 Feb 19
Michael Harrison
EntityIndividual
Shares2,868,977
Max PriceUK£0.13
SellUK£358,62118 Feb 19
John Harrison
EntityIndividual
Shares2,868,977
Max PriceUK£0.13

Ownership Breakdown


Management Team

  • Wendy Lawrence (57yo)

    CEO & Executive Director

    • Tenure: 6.3yrs
    • Compensation: UK£163.00k
  • Wayne Llewellyn (56yo)

    CEO & Clinical Director of Premier Physical Healthcare

    • Tenure: 0yrs
  • Richard Benson (51yo)

    Chief Executive Officer of About Health

    • Tenure: 3.3yrs
  • Gloria Cooke (66yo)

    Clinical Quality Director & Director

    • Tenure: 1.8yrs
    • Compensation: UK£112.00k
  • Lisa Barter-Ng (48yo)

    Finance Director & Director

    • Tenure: 1.9yrs
    • Compensation: UK£117.00k
  • Andy Gregory

    Managing Director of Vocare

    • Tenure: 0yrs
  • John Charlton

    Group Company Secretary

    • Tenure: 0yrs
  • Michael Steel (49yo)

    Executive Director

    • Tenure: 0.3yrs
  • Emma-Jayne Perez-Chies

    Director of Human Resources & Organisational Development

    • Tenure: 0yrs

Board Members

  • Tony Bourne (65yo)

    Non-Executive Director

    • Tenure: 3.9yrs
    • Compensation: UK£25.00k
  • Bob Holt (64yo)

    Non-Executive Chairman

    • Tenure: 4yrs
  • Mike Rogers (77yo)

    Non-Executive Director

    • Tenure: 3.8yrs
    • Compensation: UK£25.00k
  • Wendy Lawrence (57yo)

    CEO & Executive Director

    • Tenure: 6.3yrs
    • Compensation: UK£163.00k
  • Gloria Cooke (66yo)

    Clinical Quality Director & Director

    • Tenure: 1.8yrs
    • Compensation: UK£112.00k
  • Lisa Barter-Ng (48yo)

    Finance Director & Director

    • Tenure: 1.9yrs
    • Compensation: UK£117.00k
  • Michael Steel (49yo)

    Executive Director

    • Tenure: 0.3yrs

Company Information

Totally plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Totally plc
  • Ticker: TLY
  • Exchange: AIM
  • Founded: 1999
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: UK£16.397m
  • Shares outstanding: 182.19m
  • Website: https://www.totallyplc.com

Number of Employees


Location

  • Totally plc
  • Cardinal Square
  • First Floor West
  • Derby
  • Derbyshire
  • DE1 3 QT
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TLYAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPJan 2000
UKXADB (Deutsche Boerse AG)YesOrdinary SharesDEEURJan 2000

Biography

Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom. The company offers a range of treatments and advice for musculoskeletal injuries and conditions, s ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 20:33
End of Day Share Price2019/09/19 00:00
Earnings2019/03/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.